Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years
- People who have been diagnosed with diffuse large B-cell lymphoma (a type of blood cancer) confirmed by laboratory testing
- People whose lymphoma has come back or stopped responding to multiple previous treatments (such as chemotherapy, immunotherapy, or targeted therapy), and who have at least one tumour that is large enough to measure (5 cm or more across, or confirmed as a large lesion by scans)
- People whose scans (CT, MRI, or PET-CT) show that the tumour has a good blood supply, making it suitable for a procedure that delivers treatment through blood vessels
- People who responded well to treatments containing doxorubicin (a type of chemotherapy drug) in the past
- People with a general health and activity level rated at 2 or below on a standard medical scale (meaning they are able to care for themselves but may not be able to do heavy physical work) (confirm with trial site)
- People whose blood test results meet specific minimum standards, including: a platelet count of at least 30 × 10⁹/L; liver function within acceptable limits; kidney function within acceptable limits; and blood clotting within acceptable limits
- People who have already had at least one DEB-TACE procedure (a type of interventional treatment delivered through blood vessels) at the institution running this trial
Who may not be able to join:
- People with serious heart, lung, liver, or kidney problems, or other significant health conditions that mean they would be unlikely to tolerate the procedure used in this trial
- People with an active or uncontrolled serious infection
- People with serious problems with blood clotting or a tendency to bleed heavily
- People who are pregnant, breastfeeding, or planning to become pregnant during the study period
- People who are allergic to, or otherwise unable to receive, the materials used in the procedure or the chemotherapy drugs involved
- People with a psychiatric condition or cognitive impairment that would make it difficult to follow the treatment plan or attend follow-up appointments
- People who the trial investigators consider unsuitable for any other reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8618159117171
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate; Local Response Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.